DK3319586T3 - Farmaceutisk formulering til behandling af inflammatoriske forandringer i endetarmen - Google Patents
Farmaceutisk formulering til behandling af inflammatoriske forandringer i endetarmen Download PDFInfo
- Publication number
- DK3319586T3 DK3319586T3 DK16732617.2T DK16732617T DK3319586T3 DK 3319586 T3 DK3319586 T3 DK 3319586T3 DK 16732617 T DK16732617 T DK 16732617T DK 3319586 T3 DK3319586 T3 DK 3319586T3
- Authority
- DK
- Denmark
- Prior art keywords
- rectum
- treatment
- pharmaceutical formulation
- inflammatory changes
- inflammatory
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15175806.7A EP3115037B1 (de) | 2015-07-08 | 2015-07-08 | Pharmazeutische formulierung zur behandlung von entzündlichen veränderungen des enddarms |
| PCT/EP2016/064907 WO2017005524A1 (de) | 2015-07-08 | 2016-06-28 | Pharmazeutische formulierung zur behandlung von entzündlichen veränderungen des enddarms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3319586T3 true DK3319586T3 (da) | 2023-02-27 |
Family
ID=53540667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK16732617.2T DK3319586T3 (da) | 2015-07-08 | 2016-06-28 | Farmaceutisk formulering til behandling af inflammatoriske forandringer i endetarmen |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US10905699B2 (da) |
| EP (2) | EP3115037B1 (da) |
| JP (1) | JP6857644B2 (da) |
| CN (1) | CN107847435B (da) |
| AU (1) | AU2016290343B2 (da) |
| CA (1) | CA2986081C (da) |
| DK (1) | DK3319586T3 (da) |
| EA (1) | EA033153B1 (da) |
| ES (2) | ES2688119T3 (da) |
| FI (1) | FI3319586T3 (da) |
| HR (1) | HRP20230174T1 (da) |
| HU (1) | HUE061585T2 (da) |
| IL (1) | IL255247B (da) |
| LT (1) | LT3319586T (da) |
| MA (1) | MA42367B1 (da) |
| MD (1) | MD3319586T2 (da) |
| PL (1) | PL3319586T3 (da) |
| PT (2) | PT3115037T (da) |
| RS (1) | RS64020B1 (da) |
| SI (1) | SI3319586T1 (da) |
| UA (1) | UA120075C2 (da) |
| WO (1) | WO2017005524A1 (da) |
| ZA (1) | ZA201707777B (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022226778A1 (zh) * | 2021-04-27 | 2022-11-03 | 广州共禾医药科技有限公司 | 经直肠施用的奥司他韦或其药学上可接受的盐的药物组合物、及其制备方法和用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB701831A (en) * | 1950-10-19 | 1954-01-06 | Rudolf Von Wuelfing | Process for the production of suppositories containing medicaments |
| US3208907A (en) * | 1961-11-13 | 1965-09-28 | Lab Toraude | Stabilized salicylate compositions |
| DE3709861A1 (de) * | 1987-03-25 | 1988-10-06 | Henkel Kgaa | Emulgierende suppositoriengrundmassen und daraus hergestellte zaepfchen |
| JP2927830B2 (ja) * | 1989-09-01 | 1999-07-28 | 東京田辺製薬株式会社 | ダナゾール坐剤 |
| IT1243379B (it) | 1990-07-27 | 1994-06-10 | Giuliani Spa | Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico |
| DE29717252U1 (de) * | 1997-09-26 | 1998-02-19 | Dr. Falk Pharma GmbH, 79108 Freiburg | Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen |
| DE19849737A1 (de) * | 1998-10-28 | 2000-05-04 | Falk Pharma Gmbh | Kombinationsmittel zur Behandlung entzündlicher Darmerkrankungen |
| US20020085978A1 (en) * | 2000-11-10 | 2002-07-04 | Mina Buenafe | Degradation-resistant glucocorticosteroid formulations |
| CU23203A1 (es) * | 2002-12-27 | 2007-05-18 | Ct Ingenieria Genetica Biotech | Formulaciones que contienen agentes de accion trombolitica para su administracion por via rectal |
| WO2008156671A2 (en) * | 2007-06-13 | 2008-12-24 | Jay Pravda | Materials and methods for treatment and diagnosis of disorders associated with oxidative stress |
| JP5223307B2 (ja) * | 2006-11-17 | 2013-06-26 | 大正製薬株式会社 | 坐剤 |
| JP2012509892A (ja) * | 2008-11-26 | 2012-04-26 | サティオゲン ファーマシューティカルズ，インク． | サティオゲン類を含有する組成物及び使用の方法 |
| WO2012022796A2 (de) * | 2010-08-20 | 2012-02-23 | Boehringer Ingelheim International Gmbh | Neue kombinationen |
| CN102525883B (zh) * | 2010-12-09 | 2013-05-08 | 丽珠集团丽珠制药厂 | 一种伏立康唑栓剂及其制备方法和用途 |
| WO2015073846A1 (en) | 2013-11-15 | 2015-05-21 | Salix Pharmaceuticals, Inc. | Method of treating ulcerative colitis |
-
2015
- 2015-07-08 PT PT15175806T patent/PT3115037T/pt unknown
- 2015-07-08 EP EP15175806.7A patent/EP3115037B1/de active Active
- 2015-07-08 ES ES15175806.7T patent/ES2688119T3/es active Active
-
2016
- 2016-06-28 FI FIEP16732617.2T patent/FI3319586T3/fi active
- 2016-06-28 CA CA2986081A patent/CA2986081C/en active Active
- 2016-06-28 WO PCT/EP2016/064907 patent/WO2017005524A1/de active Application Filing
- 2016-06-28 PT PT167326172T patent/PT3319586T/pt unknown
- 2016-06-28 LT LTEPPCT/EP2016/064907T patent/LT3319586T/lt unknown
- 2016-06-28 UA UAA201800685A patent/UA120075C2/uk unknown
- 2016-06-28 RS RS20230170A patent/RS64020B1/sr unknown
- 2016-06-28 EP EP16732617.2A patent/EP3319586B1/de active Active
- 2016-06-28 HU HUE16732617A patent/HUE061585T2/hu unknown
- 2016-06-28 AU AU2016290343A patent/AU2016290343B2/en active Active
- 2016-06-28 US US15/742,710 patent/US10905699B2/en active Active
- 2016-06-28 DK DK16732617.2T patent/DK3319586T3/da active
- 2016-06-28 MA MA42367A patent/MA42367B1/fr unknown
- 2016-06-28 MD MDE20180489T patent/MD3319586T2/ro unknown
- 2016-06-28 SI SI201631664T patent/SI3319586T1/sl unknown
- 2016-06-28 ES ES16732617T patent/ES2938358T3/es active Active
- 2016-06-28 EA EA201792685A patent/EA033153B1/ru unknown
- 2016-06-28 HR HRP20230174TT patent/HRP20230174T1/hr unknown
- 2016-06-28 CN CN201680039904.2A patent/CN107847435B/zh active Active
- 2016-06-28 PL PL16732617.2T patent/PL3319586T3/pl unknown
- 2016-06-28 JP JP2018500330A patent/JP6857644B2/ja active Active
-
2017
- 2017-10-24 IL IL255247A patent/IL255247B/en active IP Right Grant
- 2017-11-16 ZA ZA2017/07777A patent/ZA201707777B/en unknown
-
2020
- 2020-11-10 US US17/094,233 patent/US11738032B2/en active Active
-
2023
- 2023-07-12 US US18/221,164 patent/US20230364113A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3383363T3 (da) | Topiske farmaceutiske formuleringer til behandling af inflammatorisk-relaterede tilstande | |
| DK3269716T3 (da) | Hidtil ukendte forbindelser og farmaceutiske sammensætninger deraf til behandling af inflammatoriske lidelser | |
| DK3119397T3 (da) | Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser | |
| DK3102213T3 (da) | Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser | |
| DK3169328T3 (da) | Quinolinderivater til behandling af inflammationssygdomme | |
| DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
| DK3390390T3 (da) | Bipyrazolylderivater egnede til behandling af autoimmunsygdomme | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| DK3395354T3 (da) | Plasminogen til anvendelse i behandling af diabetisk nefropati | |
| DK3237045T3 (da) | Indretning til indgivelse af lægemidler | |
| DK3234107T3 (da) | B-celler til in vivo-levering af terapeutiske midler | |
| DK3532029T3 (da) | Flydende farmaceutisk sammensætning | |
| DK3189074T3 (da) | Sammensætninger og metoder til behandling og forebyggelse af inflammation | |
| DK3532067T3 (da) | Liposomal formulering til anvendelse til behandling af cancer | |
| DK3391902T3 (da) | Plasminogen til anvendelse i behandlingen af diabetisk angiokardiopati | |
| DK3094322T3 (da) | Administration af tasimelteon i fastende tilstand | |
| DK3374497T3 (da) | Modificerede makrofager til anvendelse i behandlingen af kræft | |
| DK3204038T3 (da) | Sammensætninger omfattende amylase til anvendelse i behandlingen af pruritus | |
| DK3200748T3 (da) | Sammensætninger og fremgangsmåder til behandling og profylakse af infektioner på operationssted | |
| DK3149049T3 (da) | Il-22 til anvendelse til behandling af stofskiftesygdomme | |
| DK3164123T3 (da) | Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier | |
| DK3125874T3 (da) | Et terapeutisk middel til anvendelse i behandlingen af infektioner | |
| DK2886108T4 (da) | Optimeret farmaceutisk formulering til behandling af inflammatoriske ændringer af øsofagus | |
| DK3283064T3 (da) | Derivater til anvendelse i behandling af muskelatrofi | |
| DK3229827T3 (da) | Modificerede peptider og anvendelse deraf til behandling af kroniske inflammatoriske sygdomme |